WHAT DOES
OXBRYTA DO?
MUYIWA
Father, bongo player, and actual Oxbryta patient
OXBRYTA IS A ONCE-DAILY, FDA-APPROVED TREATMENT
Oxbryta may reduce sickling and help red blood cells deliver oxygen throughout the body.
Red Blood Cell
Oxbryta attaches to sickle hemoglobin to help keep it from clumping together.
Oxbryta may reduce sickling
Oxbryta may affect hemoglobin levels by impacting the first step in the process—polymerization.
Since 2019, more than 15,000 PATIENTS have
been prescribed Oxbryta*
* Based on US patient claims collected from initial approval in November 2019 up to August 2023.
SEE OXBRYTA IN ACTION
Oxbryta is a once-daily FDA-approved treatment that addresses sickle cell in a different way—by working directly on hemoglobin to interfere with the process that causes red blood cells to sickle.
"I’m in the band. I like playing my trumpet. I like hanging out with my friends and my family. So, I make sure I’m hydrated and rested."
– TULLY
Actual Oxbryta patient
TULLY
Actual Oxbryta patient
